SEC Form 4 insider trading filings tracked in real time from EDGAR

Hite Christopher — EVP & Chairman, Partnering

Insider trading activity for Hite Christopher sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: EVP & Chairman, Partnering
  • Company: Royalty Pharma plc
  • Total insider trades: 11
  • Total buy volume: $0
  • Total sell volume: $27.4M
  • Last trade: Sep 24, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Sep 22, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 3,927 $231K
Sep 22, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 96,073 $5.6M
Aug 18, 2026 Hite Christopher RRPRX RRPRX SELL 100,000 $6.0M
Jun 30, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 600 $34K
Jun 30, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 29,400 $1.7M
Jun 30, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 2,554 $146K
Jun 30, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 97,446 $5.5M
Jun 23, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 117,592 $6.4M
Jun 23, 2026 Hite Christopher RPRX Royalty Pharma plc SELL 32,408 $1.8M
May 6, 2026 Hite Christopher RPRX Royalty Pharma plc OTHER 24,263 N/A
Apr 16, 2026 Hite Christopher KLRA Kailera Therapeutics, Inc. OTHER 38,300 N/A

← All executives · Full trades feed